ArticleCrop health2026
A maize protoplast transfection system for studying the biosynthesis of volatile terpenoids.
Article in Crop health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Volatile terpenoids are produced by almost all plants. They often function as important defensive secondary metabolites. Currently, research aimed at elucidating the biosynthesis of maize terpenes is limited. Thus, a rapid and efficient platform for identifying genes involved in the synthesis/regulation of maize volatile terpenes is highly desirable. Through optimization of various conditions, including light, substrate accumulation, nutrient and ionic composition of the culture medium, culture vessel size and conditions, organic solvent extraction, and promoter selection, we established a maize protoplast transfection system for analyzing the biochemical functions of terpene synthases (TPSs) and the functions of regulatory factors, such as transcription factors. Specifically, dim light-cultured maize seedlings are first treated with methyl jasmonate, followed by preparation of protoplasts and transfection of target genes driven by the ubiquitin promoter. The transfected protoplasts were cultured overnight in glass headspace tubes. Maize protoplasts were extracted by n-pentane and concentrated, and after being heated, the volatile terpenes were absorbed by solid-phase microextraction and analyzed on a gas chromatograph. This system was successfully used to detect the products of ZmTPS10, (E)-β-farnesene and (E)-α-bergamotene and to analyze the function of the transcription factor ZmMYC2a in regulating the production of (E)-β-farnesene and (E)-α-bergamotene. Our system provides a rapid and efficient platform for studying the synthesis and regulation of maize terpene volatiles and can also be adopted for other plant species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.